BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24495951)

  • 1. Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation.
    Cho Y; Turner ND; Davidson LA; Chapkin RS; Carroll RJ; Lupton JR
    Exp Biol Med (Maywood); 2014 Mar; 239(3):302-10. PubMed ID: 24495951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
    Gozzini A; Santini V
    Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116.
    Fang JY; Chen YX; Lu J; Lu R; Yang L; Zhu HY; Gu WQ; Lu LG
    Cell Res; 2004 Jun; 14(3):217-26. PubMed ID: 15225415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrate and docosahexaenoic acid interact in alterations of specific lipid classes in differentiating colon cancer cells.
    Tylichová Z; Slavík J; Ciganek M; Ovesná P; Krčmář P; Straková N; Machala M; Kozubík A; Hofmanová J; Vondráček J
    J Cell Biochem; 2018 Jun; 119(6):4664-4679. PubMed ID: 29274292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docosahexaenoic acid and butyrate synergistically induce colonocyte apoptosis by enhancing mitochondrial Ca2+ accumulation.
    Kolar SS; Barhoumi R; Lupton JR; Chapkin RS
    Cancer Res; 2007 Jun; 67(11):5561-8. PubMed ID: 17545640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
    Kim YH; Park JW; Lee JY; Kwon TK
    Carcinogenesis; 2004 Oct; 25(10):1813-20. PubMed ID: 15142888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca(2+) accumulation in colonocytes.
    Kolar SS; Barhoumi R; Callaway ES; Fan YY; Wang N; Lupton JR; Chapkin RS
    Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G935-43. PubMed ID: 17717041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of autophagy and PPARγ protect colon cancer cells against apoptosis induced by interactive effects of butyrate and DHA in a cell type-dependent manner: The role of cell differentiation.
    Tylichová Z; Straková N; Vondráček J; Vaculová AH; Kozubík A; Hofmanová J
    J Nutr Biochem; 2017 Jan; 39():145-155. PubMed ID: 27840291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes.
    Ng Y; Barhoumi R; Tjalkens RB; Fan YY; Kolar S; Wang N; Lupton JR; Chapkin RS
    Carcinogenesis; 2005 Nov; 26(11):1914-21. PubMed ID: 15975958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells.
    Côté S; Sinnett D; Momparler RL
    Anticancer Drugs; 1998 Oct; 9(9):743-50. PubMed ID: 9840718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
    Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
    BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linoleic acid and butyrate synergize to increase Bcl-2 levels in colonocytes.
    Turk HF; Kolar SS; Fan YY; Cozby CA; Lupton JR; Chapkin RS
    Int J Cancer; 2011 Jan; 128(1):63-71. PubMed ID: 20232381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells.
    Narayanan BA; Narayanan NK; Reddy BS
    Int J Oncol; 2001 Dec; 19(6):1255-62. PubMed ID: 11713597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines.
    Ikehata M; Ueda K; Iwakawa S
    Biol Pharm Bull; 2012; 35(3):301-7. PubMed ID: 22382314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic ras alters sensitivity of mouse colonocytes to butyrate and fatty acid mediated growth arrest and apoptosis.
    Turner ND; Zhang J; Davidson LA; Lupton JR; Chapkin RS
    Cancer Lett; 2002 Dec; 186(1):29-35. PubMed ID: 12183072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of gefitinib and DNA methylation inhibitor decitabine exerts synergistic anti-cancer activity in colon cancer cells.
    Lou YF; Zou ZZ; Chen PJ; Huang GB; Li B; Zheng DQ; Yu XR; Luo XY
    PLoS One; 2014; 9(5):e97719. PubMed ID: 24874286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.